| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| July 1st, 2006 | 43 | No |
(S)-(-)-hesperidin; Cirantin; Hesperidoside; hesperidin
520-26-3; C09755; Ciratin; Hesperetin 7-O-rutinoside; Hesperidin
520-26-3; D01038; Hesperidin (JAN)
CPD-7075; hesperetin 7-(6-O-alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside; hesperidin
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | -0.55 | -18.01 | -20.11 | 8 | 15 | 0 | 234 | 610.565 | 7 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| Patent Database Links | EP0920870; EP1369489; EP1514540; EP1568283; EP1600143; EP1616873; EP1652527; EP1707192; EP1834636; EP1837026; EP1891967; EP1911358; US2004023890; US2004266999; US2006270009; US2007184133; US2007197648; US2007202195; US2007212393; US2007218111; US200724870 | ChEBI |
| Target | Transcription factor p65(Q04206)&NAD-dependent deacetylase sirtuin-1(Q96EB6)&RAC-alpha serine/threonine-protein kinase(P31749)&Protein kinase C beta type(P05771)&Cellular tumor antigen p53(P04637)&Syndecan-3(O75056) | Herbal Ingredients Targets |
